Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease : A consecutive mixed memory clinic cohort study
(2025) In Alzheimer's and Dementia 21(6).- Abstract
INTRODUCTION: Blood-based biomarkers have demonstrated high accuracy for identifying Alzheimer's disease (AD) pathology. However, the lack of representative cohorts creates a knowledge gap regarding their real-world applicability. We examined the influence of ethnicity on the diagnostic accuracy of plasma tau phosphorylated at threonine 217 (p-tau217) in identifying AD. METHODS: A total of 1170 mixed memory clinic patients originating from 91 different countries were included. Cerebrospinal fluid or amyloid positron emission tomography supplemented the diagnostic evaluation for 539 patients. Plasma was analyzed for p-tau217. RESULTS: Plasma p-tau217 concentrations did not differ between ethnic groups, and there was no influence of... (More)
INTRODUCTION: Blood-based biomarkers have demonstrated high accuracy for identifying Alzheimer's disease (AD) pathology. However, the lack of representative cohorts creates a knowledge gap regarding their real-world applicability. We examined the influence of ethnicity on the diagnostic accuracy of plasma tau phosphorylated at threonine 217 (p-tau217) in identifying AD. METHODS: A total of 1170 mixed memory clinic patients originating from 91 different countries were included. Cerebrospinal fluid or amyloid positron emission tomography supplemented the diagnostic evaluation for 539 patients. Plasma was analyzed for p-tau217. RESULTS: Plasma p-tau217 concentrations did not differ between ethnic groups, and there was no influence of ethnicity on the diagnostic accuracy of plasma p-tau217. Plasma p-tau217 demonstrated strong discriminative ability for AD and AD-pathology in our ethnically diverse cohort. DISCUSSION: Our study suggests that ethnicity does not influence the diagnostic accuracy of plasma p-tau217. Nonetheless, medical conditions influencing plasma biomarkers may disproportionally affect minoritized groups because of social determinants of health. Highlights: Plasma tau phosphorylated at threonine 217 (p-tau217) was highly accurate in the identification of Alzheimer's disease. Geographic origin did not influence the precision of plasma p-tau217. Kidney function may influence p-tau217 concentrations. Representative inclusion in studies and trials should be a priority.
(Less)
- author
- Kjaergaard, Daniel
; Nielsen, T. Rune
; Stomrud, Erik
LU
; Palmqvist, Sebastian
LU
; Bali, Divya
LU
; Dolado, Anna Orduña
LU
; Janelidze, Shorena
LU
; Hansson, Oskar
LU
; Waldemar, Gunhild
and Simonsen, Anja Hviid
- organization
- publishing date
- 2025-06
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Alzheimer's disease, amyloid pathology, blood-based biomarkers, cerebrospinal fluid, confounders, dementia, diversity, ethnicity, phosphorylated tau, plasma biomarkers, racial groups
- in
- Alzheimer's and Dementia
- volume
- 21
- issue
- 6
- article number
- e70315
- publisher
- Wiley
- external identifiers
-
- pmid:40501109
- scopus:105008501896
- ISSN
- 1552-5260
- DOI
- 10.1002/alz.70315
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2025 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
- id
- 4c50b28b-21c8-4a63-8a88-2016c844038c
- date added to LUP
- 2025-12-16 14:01:33
- date last changed
- 2025-12-16 14:02:26
@article{4c50b28b-21c8-4a63-8a88-2016c844038c,
abstract = {{<p>INTRODUCTION: Blood-based biomarkers have demonstrated high accuracy for identifying Alzheimer's disease (AD) pathology. However, the lack of representative cohorts creates a knowledge gap regarding their real-world applicability. We examined the influence of ethnicity on the diagnostic accuracy of plasma tau phosphorylated at threonine 217 (p-tau217) in identifying AD. METHODS: A total of 1170 mixed memory clinic patients originating from 91 different countries were included. Cerebrospinal fluid or amyloid positron emission tomography supplemented the diagnostic evaluation for 539 patients. Plasma was analyzed for p-tau217. RESULTS: Plasma p-tau217 concentrations did not differ between ethnic groups, and there was no influence of ethnicity on the diagnostic accuracy of plasma p-tau217. Plasma p-tau217 demonstrated strong discriminative ability for AD and AD-pathology in our ethnically diverse cohort. DISCUSSION: Our study suggests that ethnicity does not influence the diagnostic accuracy of plasma p-tau217. Nonetheless, medical conditions influencing plasma biomarkers may disproportionally affect minoritized groups because of social determinants of health. Highlights: Plasma tau phosphorylated at threonine 217 (p-tau217) was highly accurate in the identification of Alzheimer's disease. Geographic origin did not influence the precision of plasma p-tau217. Kidney function may influence p-tau217 concentrations. Representative inclusion in studies and trials should be a priority.</p>}},
author = {{Kjaergaard, Daniel and Nielsen, T. Rune and Stomrud, Erik and Palmqvist, Sebastian and Bali, Divya and Dolado, Anna Orduña and Janelidze, Shorena and Hansson, Oskar and Waldemar, Gunhild and Simonsen, Anja Hviid}},
issn = {{1552-5260}},
keywords = {{Alzheimer's disease; amyloid pathology; blood-based biomarkers; cerebrospinal fluid; confounders; dementia; diversity; ethnicity; phosphorylated tau; plasma biomarkers; racial groups}},
language = {{eng}},
number = {{6}},
publisher = {{Wiley}},
series = {{Alzheimer's and Dementia}},
title = {{Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease : A consecutive mixed memory clinic cohort study}},
url = {{http://dx.doi.org/10.1002/alz.70315}},
doi = {{10.1002/alz.70315}},
volume = {{21}},
year = {{2025}},
}